Role of Th17 Cells in the Pathogenesis of Human IBD

Overview

Journal ISRN Inflamm

Date 2014 Aug 8

PMID 25101191

Citations 143

Authors

Julio Galvez

Affiliations

Soon will be listed here.

Abstract

The gastrointestinal tract plays a central role in immune system, being able to mount efficient immune responses against pathogens, keeping the homeostasis of the human gut. However, conditions like Crohn's disease (CD) or ulcerative colitis (UC), the main forms of inflammatory bowel diseases (IBD), are related to an excessive and uncontrolled immune response against normal microbiota, through the activation of CD4(+) T helper (Th) cells. Classically, IBD was thought to be primarily mediated by Th1 cells in CD or Th2 cells in UC, but it is now known that Th17 cells and their related cytokines are crucial mediators in both conditions. Th17 cells massively infiltrate the inflamed intestine of IBD patients, where they produce interleukin- (IL-) 17A and other cytokines, triggering and amplifying the inflammatory process. However, these cells show functional plasticity, and they can be converted into either IFN- γ producing Th1 cells or regulatory T cells. This review will summarize the current knowledge regarding the regulation and functional role of Th17 cells in the gut. Deeper insights into their plasticity in inflammatory conditions will contribute to advancing our understanding of the mechanisms that regulate mucosal homeostasis and inflammation in the gut, promoting the design of novel therapeutic approaches for IBD.

Citing Articles

Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions.

Little R, Jayawardana T, Koentgen S, Zhang F, Connor S, Boussioutas A eGastroenterology. 2025; 2(1):e100006.

PMID: 39944752 PMC: 11770437. DOI: 10.1136/egastro-2023-100006.

Translating Human and Animal Model Studies to Dogs' and Cats' Veterinary Care: Beta-Glucans Application for Skin Disease, Osteoarthritis, and Inflammatory Bowel Disease Management.

Amaral A, Risolia L, Rentas M, Marchi P, Balieiro J, Vendramini T Microorganisms. 2024; 12(6).

PMID: 38930453 PMC: 11205328. DOI: 10.3390/microorganisms12061071.

How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer.

Majumder A, Bano S Biomolecules. 2024; 14(6).

PMID: 38927037 PMC: 11201633. DOI: 10.3390/biom14060633.

A broken network of susceptibility genes in the monocytes of Crohn's disease patients.

Liu H, Guan L, Su X, Zhao L, Shu Q, Zhang J Life Sci Alliance. 2024; 7(9).

PMID: 38925865 PMC: 11208737. DOI: 10.26508/lsa.202302394.

The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.

Al-Sofi R, Bergmann M, Nielsen C, Andersen V, Skov L, Loft N Int J Mol Sci. 2024; 25(11).

PMID: 38891983 PMC: 11171831. DOI: 10.3390/ijms25115793.

References

Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F . Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011; 63(8):2504-15. DOI: 10.1002/art.30332. View

Zenewicz L, Antov A, Flavell R . CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med. 2009; 15(5):199-207. DOI: 10.1016/j.molmed.2009.03.002. View

Ohnmacht C, Marques R, Presley L, Sawa S, Lochner M, Eberl G . Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity. Cell Microbiol. 2011; 13(5):653-9. DOI: 10.1111/j.1462-5822.2011.01577.x. View

Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls J . Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006; 12(5):382-8. DOI: 10.1097/01.MIB.0000218764.06959.91. View

Hontecillas R, Horne W, Climent M, Guri A, Evans C, Zhang Y . Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease. Mucosal Immunol. 2010; 4(3):304-13. PMC: 3049196. DOI: 10.1038/mi.2010.75. View

De Nitto D, Sarra M, Pallone F, Monteleone G . Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol. 2010; 16(29):3638-41. PMC: 2915423. DOI: 10.3748/wjg.v16.i29.3638. View

Garrido-Mesa N, Utrilla P, Comalada M, Zorrilla P, Garrido-Mesa J, Zarzuelo A . The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem Pharmacol. 2011; 82(12):1891-900. DOI: 10.1016/j.bcp.2011.09.004. View

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

Dang E, Barbi J, Yang H, Jinasena D, Yu H, Zheng Y . Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011; 146(5):772-84. PMC: 3387678. DOI: 10.1016/j.cell.2011.07.033. View

10.

Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y . Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol. 2004; 110(1):55-62. DOI: 10.1016/j.clim.2003.09.013. View

11.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

12.

Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Flavell R . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29(6):947-57. PMC: 3269819. DOI: 10.1016/j.immuni.2008.11.003. View

13.

Denning T, Norris B, Medina-Contreras O, Manicassamy S, Geem D, Madan R . Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol. 2011; 187(2):733-47. PMC: 3131424. DOI: 10.4049/jimmunol.1002701. View

14.

Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K . Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem. 1997; 272(23):14893-8. DOI: 10.1074/jbc.272.23.14893. View

15.

Ivanov I, de Llanos Frutos R, Manel N, Yoshinaga K, Rifkin D, Sartor R . Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008; 4(4):337-49. PMC: 2597589. DOI: 10.1016/j.chom.2008.09.009. View

16.

Ouyang W, Ranganath S, Weindel K, Bhattacharya D, MURPHY T, Sha W . Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998; 9(5):745-55. DOI: 10.1016/s1074-7613(00)80671-8. View

17.

Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C . The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009; 31(4):677-89. DOI: 10.1016/j.immuni.2009.08.020. View

18.

Esser C, Rannug A, Stockinger B . The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009; 30(9):447-54. DOI: 10.1016/j.it.2009.06.005. View

19.

Raza A, Shata M . Letter: pathogenicity of Th17 cells may differ in ulcerative colitis compared with Crohn's disease. Aliment Pharmacol Ther. 2012; 36(2):204. DOI: 10.1111/j.1365-2036.2012.05124.x. View

20.

Thompson A, Lees C . Genetics of ulcerative colitis. Inflamm Bowel Dis. 2011; 17(3):831-48. DOI: 10.1002/ibd.21375. View